Frank van Leth

Latest

• Clinical Reasoning Underlying Guideline Nonadherence in Urinary Tract Infections in Nursing Homes
• Rifapentine access in Europe: growing concerns over key tuberculosis treatment component
• Unbiased antimicrobial resistance prevalence estimates through population-based surveillance
• Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model
• Diapers as Promising Alternative Collection Method for Urine Specimens in Nursing Home Residents: A Noninferiority Study.
• Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future.
• Antimicrobial resistance among uropathogens in the Asia-Pacific region: a systematic review
• Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model.
• Appropriateness of diagnosis and antibiotic use in sepsis patients admitted to a tertiary hospital in Indonesia.
• Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
• Laboratory-based versus population-based surveillance of antimicrobial resistance to inform empirical treatment for suspected urinary tract infection in Indonesia
• Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials.
• The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR.
• Sensitivity of point-of-care testing C reactive protein and procalcitonin to diagnose urinary tract infections in Dutch nursing homes: PROGRESS study protocol
• Changes in disclosure, adherence and healthcare interactions after the introduction of immediate ART initiation: an analysis of patient experiences in Swaziland
• Bridging the TB data gap: in silico extraction of rifampicin-resistant tuberculosis diagnostic test results from whole genome sequence data.
• Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling.
• The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation.
• Pharmacy-based hypertension care employing mHealth in Lagos, Nigeria - a mixed methods feasibility study.
• Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries
• Predictive value of the urinary dipstick test in the management of patients with urinary tract infection-associated symptoms in primary care in Indonesia: a cross-sectional study.
• Testing for LTBI: more of the same or a step forward?
• Relapse-free cure from multidrug-resistant tuberculosis in Germany
• Time to revise WHO-recommended definitions of MDR-TB treatment outcomes
• Reply: Benefit of the Shorter Multidrug-Resistant Tuberculosis Treatment Regimen in California and Modified Eligibility Criteria
• Treatment outcomes of MDR-TB and HIV co-infection in Europe
• An easy tool to assess ventilation in health facilities as part of air-borne transmission prevention: a cross-sectional survey from Uganda
• Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia
• Rapid assessment of antimicrobial resistance prevalence using a Lot Quality Assurance sampling approach
• Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review
• Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure
• Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial
• Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe
• Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design
• Treatment Outcomes in Multidrug-Resistant Tuberculosis
• TB-HIV co-infection in the Netherlands: estimating prevalence and under-reporting in national registration databases using a capture-recapture analysis
• Viral Load and Risk of Tuberculosis in HIV Infection
• More on Treatment Outcomes in Multidrug-Resistant Tuberculosis
• Numbers needed to treat to prevent tuberculosis
• Factors associated with poor knowledge among adults on tuberculosis in Bangladesh: results from a nationwide survey
• Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey
• Multidrug-resistant tuberculosis in europe, 2010-2011
• Latent tuberculosis infection as a target for tuberculosis control
• Risk assessment of tuberculosis in immunocompromised patients. A TBNET study
• Antimicrobial drug resistance among clinically relevant bacterial isolates in sub-Saharan Africa: a systematic review
• Care seeking in tuberculosis: results from a countrywide cluster randomised survey in Bangladesh
• Embracing the challenges of HIV-TB co-infection in children
• Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement
• Antiretroviral therapy and tuberculosis: does the regimen matter?
• Design of pragmatic trials of tuberculosis interventions
• Healthcare workers' challenges in the implementation of tuberculosis infection prevention and control measures in Mozambique
• TB diagnostic process management of patients in a referral hospital in Mozambique in comparison with the 2007 WHO recommendations for the diagnosis of smear-negative pulmonary TB and extrapulmonary TB
• Are routine tuberculosis programme data suitable to report on antiretroviral therapy use of HIV-infected tuberculosis patients?
• Comparison of direct versus concentrated smear microscopy in detection of pulmonary tuberculosis
• Epidemiology of tuberculosis in an urban slum of Dhaka City, Bangladesh
• Health workers' performance in the implementation of Patient Centred Tuberculosis Treatment (PCT) strategy under programmatic conditions in Tanzania: a cross sectional study
• Predictive value of the tuberculin skin test among newly arriving immigrants
• Risk of tuberculosis after antiretroviral treatment initiation: a comparison between efavirenz and nevirapine using inverse probability weighting
• Role of the QuantiFERON(R)-TB Gold In-Tube assay in screening new immigrants for tuberculosis infection
• Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery
• Implementation and effect of intensified case finding on diagnosis of tuberculosis in a large urban HIV clinic in Uganda: a retrospective cohort study
• Missed opportunities in tuberculosis control in The Netherlands due to prioritization of contact investigations
• Multidrug resistance among new tuberculosis cases: detecting local variation through lot quality-assurance sampling
• Adherence by Dutch public health nurses to the national guidelines for tuberculosis contact investigation
• Adherence to tuberculosis therapy among patients receiving home-based directly observed treatment: evidence from the United Republic of Tanzania
• Socio economic position in TB prevalence and access to services: results from a population prevalence survey and a facility-based survey in Bangladesh
• The effect of tuberculosis and antiretroviral treatment on CD4+ cell count response in HIV-positive tuberculosis patients in Mozambique
• Contact tracing in low-incidence tuberculosis settings
• Incidence and Predictors of Mortality and the Effect of Tuberculosis Immune Reconstitution Inflammatory Syndrome in a Cohort of TB/HIV Patients Commencing Antiretroviral Therapy
• Guidelines for conducting tuberculin skin test surveys in high-prevalence countries